We previously illustrated that high expression of IGF-1R correlates with expression of cancer stemness markers (OCT4 and NANOG) and early recurrence [27,28] and with sorafenib resistance properties in HCC [11,66]. The gene discussed is NANOG; the disease is hepatocellular carcinoma.